Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-24-071732
Filing Date
2024-06-14
Accepted
2024-06-14 15:59:18
Documents
1
Group Members
DR. JAMES I. HEALYDR. MAHA KATABISOFINNOVA MANAGEMENT XI, L.L.C.SOFINNOVA MANAGEMENT XI, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2417280d1_sc13d.htm SC 13D 141288
  Complete submission text file 0001104659-24-071732.txt   143029
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners XI, L.P. (Filed by) CIK: 0001882303 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Subject) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94532 | Film No.: 241044565
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)